Cagrilintide 10mg

Cagrilintide is a long-acting amylin analogue being investigated for its effects on appetite regulation, satiety, body weight, and metabolic pathways. Research indicates that cagrilintide can influence hunger and fullness signals, making it an important compound in ongoing obesity and metabolic-health research.

Cagrilintide 10mg is supplied as a research compound for laboratory investigation of amylin-receptor signaling, appetite-related pathways, and metabolic regulation. Clinical research has also evaluated cagrilintide as a standalone compound and in combination with semaglutide as CagriSema.

Research Areas:

Amylin receptor signaling
Appetite and satiety research
Body-weight regulation
Metabolic health research
Glucose and energy-balance studies
Combination peptide research

Research Use Only — Not for human or veterinary use.